| 注册
首页|期刊导航|生物医学研究杂志(英文版)|The potential of genetically-engineered pigs in providing an alternative source of organs and cells for transplantation

The potential of genetically-engineered pigs in providing an alternative source of organs and cells for transplantation

David K.C.Cooper Hidetaka Hara Mohamed Ezzelarab Rita Bottino Massimo Trucco Carol Phelps David Ayares

生物医学研究杂志(英文版)2013,Vol.27Issue(4):249-253,5.
生物医学研究杂志(英文版)2013,Vol.27Issue(4):249-253,5.DOI:10.7555/JBR.27.20130063

The potential of genetically-engineered pigs in providing an alternative source of organs and cells for transplantation

The potential of genetically-engineered pigs in providing an alternative source of organs and cells for transplantation

David K.C.Cooper 1Hidetaka Hara 1Mohamed Ezzelarab 1Rita Bottino 2Massimo Trucco 2Carol Phelps 3David Ayares3

作者信息

  • 1. Thomas E.Starzl Transplantation Institute,University of Pittsburgh Medical Center,Pittsburgh,PA 15261,USA
  • 2. Division of Immunogenetics,Children's Hospital of Pittsburgh,University of Pittsburgh,Pittsburgh,PA 15261,USA
  • 3. Revivicor,Inc,Blacksburg,VA 24060,USA
  • 折叠

摘要

关键词

pig, blood transfusion/ pig, genetic-engineered/ pig, islets/ pig, organs/ xenotransplantation

Key words

pig, blood transfusion/ pig, genetic-engineered/ pig, islets/ pig, organs/ xenotransplantation

引用本文复制引用

David K.C.Cooper,Hidetaka Hara,Mohamed Ezzelarab,Rita Bottino,Massimo Trucco,Carol Phelps,David Ayares..The potential of genetically-engineered pigs in providing an alternative source of organs and cells for transplantation[J].生物医学研究杂志(英文版),2013,27(4):249-253,5.

基金项目

Mohamed Ezzelarab is supported in part by the Joseph A.Patrick Research Fellowship in Transplantation of the Thomas E.Starzl Transplantation Institute of the University of Pittsburgh.Hidetaka Hara MD,PhD is supported in part by NIH grant # 1RO3A1096296-01.Studies on xenotransplantation at the Thomas E.Starzl Transplantation Institute are supported in part by CMRF (competitive medical research funding) from the University of Pittsburgh Medical Center,NIH grants # 1U19AI090959-01,# U01A1066331,and # 1PO1 HL107152,by an Ocular Tissue Engineering and Regenerative Ophthalmology (OTERO) Postdoctoral Fellowship,and by Sponsored Research Agreements between the University of Pittsburgh and Revivicor,Inc.,Blacksburg,VA.Studies on xenotransplantation at the Nanjing Medical University are supported in part by a Sponsored Research Agreement between the Nanjing Medical University and Lung Biotechnology,Nanjing,China. (competitive medical research funding)

生物医学研究杂志(英文版)

1674-8301

访问量2
|
下载量0
段落导航相关论文